Key Insights

Highlights

Success Rate

90% trial completion (above average)

Published Results

13 trials with published results (18%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

6.9%

5 terminated out of 72 trials

Success Rate

89.6%

+3.0% vs benchmark

Late-Stage Pipeline

32%

23 trials in Phase 3/4

Results Transparency

30%

13 of 43 completed with results

Key Signals

13 with results90% success

Data Visualizations

Phase Distribution

65Total
Not Applicable (31)
Early P 1 (1)
P 1 (2)
P 2 (8)
P 3 (14)
P 4 (9)

Trial Status

Completed43
Unknown8
Recruiting6
Terminated5
Not Yet Recruiting4
Active Not Recruiting3

Trial Success Rate

89.6%

Benchmark: 86.6%

Based on 43 completed trials

Clinical Trials (72)

Showing 20 of 20 trials
NCT07701863Not ApplicableRecruiting

F-GYN for Vaginal Dryness and Vulvovaginal Atrophy

NCT04807894Phase 4Terminated

Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo

NCT05379153Phase 3RecruitingPrimary

Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial

NCT07526948Phase 4Not Yet Recruiting

Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV

NCT05457972Phase 4Recruiting

Postpartum Vaginal Estrogen for Breastfeeding Patients

NCT07346287Phase 4CompletedPrimary

ASSIST-VLA: Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser Therapy

NCT05953090Not ApplicableRecruiting

VALOR: Vaginal Atrophy & Long-term Observation of Recovery

NCT06028009Not ApplicableActive Not Recruiting

PRP Injections for Genitourinary Syndrome of Menopause

NCT07024667Not ApplicableRecruiting

Clinical and Molecular Study to Evaluate the Effect of the Pixel CO2 Laser (FemiLiftTM) for the Treatment of Vulvo-Vaginal Atrophy

NCT05483634Not Yet Recruiting

Compare Vaginal Estrogen and Platelet-rich Plasma Over Women With Genitourinary Syndrome of Menopause

NCT06000202Not ApplicableCompletedPrimary

Elastographic Improvement of Vaginal Atrophy Treated by Erbium Yag Laser

NCT04081805Not ApplicableActive Not RecruitingPrimary

LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2)

NCT04079218Phase 4Completed

Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial

NCT06391372Phase 3Active Not Recruiting

Effect of Local Estriol Treatment Before Vaginal Repair Surgery

NCT06207227Not ApplicableCompletedPrimary

Clinical Performance and Safety of the VITA AV Clinical System

NCT04735549Not ApplicableCompleted

Vulvovaginal Atrophy Correction Using Neodymium Laser

NCT05335317Not ApplicableRecruiting

Treatment of Vaginal Atrophy With Low Intensity Nanosecond Neodymium Laser

NCT05463081Not ApplicableCompleted

Clinical Trial of "Magic Gyno" Laser Device

NCT04493333Phase 2TerminatedPrimary

Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors

NCT06353945Not ApplicableCompletedPrimary

Perceived Effectiveness of the Vaginal Moisturizer Investigational Product Under Normal Conditions of Use.

Scroll to load more

Research Network

Activity Timeline